Literature DB >> 11911974

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas.

Koji Matsumoto1, Hiroyuki Yoshikawa, Toshiharu Yasugi, Takashi Onda, Shunsuke Nakagawa, Manabu Yamada, Kei Kawana, Takeo Minaguchi, Katsutoshi Oda, Yoko Hasumi, Yuji Taketani.   

Abstract

The distribution of metastatic pelvic lymph nodes (PLNs) and aortic lymph nodes (ALNs) in 27 node-positive endometrial carcinomas (ECs) was analyzed in comparison with that in 25 node-positive cervical carcinomas (CCs) and 58 node-positive ovarian carcinomas (OCs). All patients underwent systematic pelvic and aortic lymphadenectomy. Lymph nodes were classified into the five subgroups: ALN above the inferior mesenteric artery (IMA; A1), ALN below the IMA (A2), the common iliac and sacral LNs (P1), the internal and external iliac LNs and obturator LNs (P2) and the suprainguinal LNs (P3). EC was similar to CC in that metastases to P2 were more frequent compared to A1 or A2, whereas EC and OC shared a common feature in that A1, A2 and P2 were involved at high rates. ALN metastases were significantly associated with P1 positivity in both EC and CC (P<0.05), but not in OC. However, the incidence of both ALN and PLN metastases in EC (67%) was similar to that in OC (61%), being much higher than that in CC (36%). ALN involvement alone was observed in 7% for EC, 0% for CC and 21% for OC. Based on the distribution of LN metastases, it appears that CC metastasizes primarily to PLN, whereas OC metastasizes almost equally to both PLN and ALN. Interestingly, EC can directly metastasize to both PLN and ALN with PLN metastases being dominant, a distinct lymphatic spread pattern better viewed as being somewhere between CC and OC.

Entities:  

Mesh:

Year:  2002        PMID: 11911974     DOI: 10.1016/s0304-3835(01)00803-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 2.  Lymphadenectomy for endometrial cancer: is paraaortic lymphadenectomy necessary?

Authors:  Nobuo Yaegashi; Kiyoshi Ito; Hitoshi Niikura
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

3.  Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.

Authors:  Sanjeev Kumar; Karl C Podratz; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Michaela E McGree; William A Cliby; Gary L Keeney; Gillian Thomas; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2013-10-09       Impact factor: 5.482

Review 4.  Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer.

Authors:  Yukiharu Todo; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2012-12-01       Impact factor: 3.402

5.  Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer.

Authors:  Sho Takeshita; Yukiharu Todo; Kazuhira Okamoto; Satoko Sudo; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2016-04-19       Impact factor: 4.401

6.  Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis.

Authors:  Yukiharu Todo; Sho Takeshita; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2017-05-22       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.